Updates are available Correction dated 2025-08-29
Click to view Correction: https://doi.org/10.1186/s13287-025-04566-1
-
Authors
Liu, Xiong
Huang, Xianwei
Huang, Xiaodong
Liu, Siyao
Hu, Jun
Lin, Jiyan
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Xiamen (3502Z202374002)
Natural Science Foundation of Fujian Province (2024J011359)
- License Information
-
More Information
Article History
Received: 15 January 2025
Accepted: 2 July 2025
First Online: 6 August 2025
Change Date: 29 August 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13287-025-04566-1
Declarations
:
: All experimental procedures related to the study titled “Emodin-Enhanced hUC-MSC Extracellular Vesicles Alleviate Acute Pancreatitis by Targeting Inflammation and Pyroptosis” were approved by the Institutional Ethics Committee of the First Affiliated Hospital of Xiamen University, with approval number XMULAC20240193, on Aug 23, 2024.The work has been reported in line with the ARRIVE guidelines 2.0.Clinical trial number: not applicable.
: The authors declare that they have not use AI-generated work in this manuscript.
: The authors declare that they have no conflicts of interest regarding the publication of this manuscript. There are no financial or personal relationships with other people or organizations that could inappropriately influence (bias) this work.The original source IMMOCELL( ) has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent.
